Navigation Links
New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
Date:6/24/2013

BOSTON, June 24, 2013 /PRNewswire/ --

During the Drug Information Association's (DIA) annual meeting today, Veeva Systems previewed its new Veeva Vault Investigator Portal. As a companion product to Vault eTMF, Vault Investigator Portal enables fast collection, sharing and tracking of all investigator content from a single platform. Veeva has specifically designed its new Investigator Portal to speed study start-up by simplifying the overall trial document management process and providing bi-directional, direct access to the eTMF.

     (Logo: http://photos.prnewswire.com/prnh/20120425/527164)

     (Photo: http://photos.prnewswire.com/prnh/20130624/622707 )

Clinical trials are one of the most complex areas of a life sciences company's operations, requiring global reach, coordination and tracking across multiple stakeholders. Investigators and site personnel spend hundreds of hours performing redundant tasks across multiple sponsors and systems. Most trial technologies hinder investigator efficiency and breed frustration. Veeva's cloud-based Vault Investigator Portal orchestrates collaboration with site personnel for more efficient operations.

"Without a doubt, the back and forth between investigators and the CRO or sponsor is causing huge delays in study start-up. Most of these documents are still exchanged as paper, which is slow and adds expense. Sponsors and CROs must find ways to improve the efficiency while protecting the increasingly important site relationship," said Michael Burton, director of clinical product strategy at Veeva.

Veeva's Vault Investigator Portal helps streamline trials and increase efficiency with features that lessen the workload for sponsors and investigators, including:  

  • Single source for sponsors, CROs and investigator sites to submit and access documents
  • Direct placement of site documents into the eTMF
  • Two-way channel for exchanging documents, including safety alerts and site training videos
  • Prioritized to-do lists and associated documents packaged and pushed to investigator sites

"With Vault Investigator Portal, sponsors and CROs will benefit from better document tracking and placement into the eTMF," concluded Burton. "The ease-of-use and efficiency for investigators will make working with the sponsor and CRO more attractive, which should keep investigators coming back for trial after trial."

Also announced at DIA 2013 today, Veeva adds critical publishing capabilities to Vault Submissions - the industry's first cloud-based application for managing submissions content. Visit the company's booth # 1557 for demonstrations of the new Vault Investigator Portal as well as Vault Submissions.

About Veeva Vault Development Suite

Vault Investigator Portal is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation.

About Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information, visit http://www.veeva.com.

Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

Media Contact
Lisa Barbadora
Veeva Systems, Inc.  
pr@veevasystems.com


'/>"/>
SOURCE Veeva Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IMS Health Advances Cloud-Based Social Media Analytics with Acquisition of Semantelli
2. The House Call Reinvented: Video Creates Personal Doctor-Patient Connection Via Cloud-Based Remote Patient Monitoring Service
3. Amdocs Launches Cloud-Based eHealth Solutions to Give Service Providers Fast Entry to Growing Market
4. Desitin Pharmaceuticals Selects Cloud-Based Veeva CRM to Support Expansion into the UK Market
5. Proton Pharma and Rottapharm Switch to Cloud-Based Veeva CRM for its Flexibility to Meet Unique Local Needs in Greece
6. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
7. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
8. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators
11. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):